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Coccidioidomycosis is a disease of protean
manifestations, and in the earlier phases poses a
difficult problem in prognostication for the indi-
vidual patient. Because of the vagaries of this
disease, any additional objective laboratory test
of the severity of the disease would be of great
value to the clinician in prognostication and
management of the patient. For that reason, 40
patients with various types of coccidioidomycosis
were studied with respect to alterations of their
serum protein profiles, the results of complement
fixation and skin tests with coccidioidin, and
conventional laboratory tests such as the erythro-
cyte sedimentation rate and hematocrit.
LINJCAL DIsCUssION
Coccidioidomycosis is, in most patients, a
relatively benign, self-limited infection. In rela-
tively few patients, however, the primary pulmo-
nary infection is followed by progressive dissemi-
nation. This spread may occur to almost any
organ with the exception of the gastro-intestinal
tract. Dissemination into the brain via the me-
ninges particularly threatens serious consequences
for the patient. Alter the acute pulmonary lesion
has subsided, a solitary cyst or coccidioidoma,
both relatively benign lesions, may remain. How-
ever, in a few patients, progressive lung disease
may occur, frequently associated with dissemi-
nation elsewhere in the body.
The acute pulmonary infection may be associ-
ated with toxic erythema or cutaneous signs of
hypersensitivity (erythema nodosum and/or cry-
thema multiforme). Other manifestations of
hypersensitivity may include arthralgias and
conjunctivitis. These symptoms usually indicate
an excellent prognosis for the patient (1—5).
This study is based on 40 patients representing
the common forms of coccidioidomycosis. They
were categorized into four main groups on the
basis of their clinical manifestations (Table I).
These 40 patients represent a fairly typical cross-
section of those seen in a county hospital in an
endemic area.
These categories were as follows:
I. Primary pulmonary infection (9 patients)
147
II. Benign residual coccidioidal lesions of the
lung and the pleura (4 patients)
III. Chronic dissemination (23 patients)
IV. Meningitis (4 patients, one with additional
dissemination elsewhere and another with
a resolving lung infection).
There were no patients with primary inoculation
coccidioidomycosis as reported by Wilson (6), or
patients with acute crythema nodosum since these
arc not usually referred to the hospital for treat-
ment.
Whether dissemination does occur depends on
many factors, most of which are poorly under-
tood: race, the presence of diabetes mcllitus, a
lymphomatous disease, malnutrition or preg-
nancy.
Gifford, ci al. (7) estimated that Mexicans are
approximately 3 times, Negroes 14 times, and
Filipinos 175 times more prone to develop dis-
seminated coccidioidomycosis than Caucasians
(5). Huntington confirms these ratios (4), but
states however that Mexicans have the same
susceptibility as Caucasians. Adult females with-
stand the infection better than men, and it is
interesting that erythema nodosum, a good prog-
nostic sign, occurs in about 25% of women in
contrast to 5% of men (2). A notable exception
however is the vulnerability of women to dis-
semination during pregnancy (9).
Chronic meningitis, sometimes a solitary mani-
festation, has a predilection for Caucasian males,
in contrast to the Negro or Filipino male who
usually has severe generalized dissemination as-
sociated with acute meningitis (10).
In the 40 patients of this series, 30 were men and
10 were women. It can be seen that the severity
of the disease may be related to the race and sex
of the patient (Table II).
The patients were grouped into four clinical
categories based upon the clinical impression at
the time the patient was examined and the serum
obtained for analysis (Table III). Silent foci of
infection in such organs as the liver, spleen, and
joints might have been undetected.
Three patients had diabetes mellitus (one
Negro, one Caucasian female, and one Mexican
male). One Negro male had discoid lupus ery-
thematosus. Awareness of other concomitant
disease is necessary in determining prognosis, and
evaluating its possible effects on the serum protein
profile. When, for example, a female Caucasian
develops disseminated disease, this may in some
instances be attributable to an underlying con-
dition such as diabetes or pregnancy which may
alter host defenses.
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Num-
ber
Severity
Mod- Se-
1 erate vere
Male Negroes
Female Negroes
Male Caucasians
Female Caucasians
Male Filipinos
Male Mexicans
Female Mexicans
10
5
8
4
6
6
1
0
2
3
3
1
4
1
5
3
4
0
5
0
0
5
0
1
1
0
2
0
SEROLOGICAL DISCUSSION
Coccidioidin, a filtrate of liquid cultures of
Coccidioides immitis, is used for the various tests
to measure the status of the disease, such as the
skin test, precipitin test, and the complement
fixation test (11—15).
When coccidioidin is injected intradermally a
delayed type of reaction occurs which is read alter
24 and 48 hours. Repeated testing does not sensi-
tize the skin of the patient to the antigen nor does
it result in a rise in the complement fixation or
precipitin titers. The skin sensitivity cannot be
passively transferred (15). A positive test indi-
cates that a patient has, or has had at any time
in the past, an infection with Coccidioides inzmitis.
Almost all patients will have a positive skin re-
action after the third week (16). Patients with
primary infection and erythema nodosum usually
show marked hypersensitivity upon skin testing
(17). When dissemination occurs, skin reactivity
may decrease or disappear. Sensitivity to skin
testing does not preclude dissemination but indi-
cates that the individual patient may still possess
significant resistance to the infection (17).
All of the patients of this series were skin
tested. If the first skin test was negative (1:100),
a second test (1:10) was performed. Seventeen
were positive with the first strength, seven with
the second strength and sixteen were negative
with both strengths. With increased severity of
disease the skin response was less marked (Table
IV).
Smith, in a study of 100 patients with dissemi-
nation (15) found 30 who reacted to a 1:100 dilution
of skin test antigen. Of 78 who reacted to a 1:10
dilution, 30 (39%) did not react to the more dilute
antigen. This is similar to the results in the 23
patients with dissemination in this series, 12
patients (52%) being negative to 1:10, 7 (30%)
positive to 1:10, and 4 (18%) positive to 1:100.
The preeipitin test is of value in establishing
the diagnosis, but has little prognostic signifi-
cance. Preeipitins usually appear in the serum
after the skin test becomes positive, but disappear
after 3 or 4 months (18—19). The complement
Primary
Lung
Infec-
lion
Dissemi-
nation
Menin-
gitis
Benign
Solitary
Lung
Lesion
Male Negro
Female Negro
Male Caucasian
Female Caucasian
Male Filipino
Male Mexican
Female Mexican
2
0
1
1
1
4
0
9
7
5
3
0
5
2
1
23
0
0
4
0
0
0
0
4
1
0
0
3
0
0
0
4
TABLE IV
Skin Test
Severity
Mild Moderate Severe
1st strength positive
2nd strength positive
negative
9
3
2
14
6
1
10
17
2
3
4
9
fixing antibodies, if they subsequently appear,
develop more slowly than the preeipitins. A rising
titer is usually interpreted as being indicative of
a progressively increasing severity of infection,
whereas regression is considered to be prog-
nostieally encouraging. A high titer, which is per-
sistent, usually indicates dissemination. The rise
in titer of complement fixing antibodies does not
indicate humoral protection of the patient from
the progressive infection however, because of
significant cross-reactivity may not always be
specifically attributed to coccidioidomyeosis.
Complement fixation tests were performed on
all patients in this series (Table V). There ap-
peared to be less skin reactivity to the skin test
in those patients having the higher complement
fixation titers.
Meningitis has been categorized as a separate
group because it is believed that the skin test and
complement fixation titer do not accurately indi-
cate the prognosis in the presence of this compli-
cation. The complement fixation test may be
positive in a low titer and the skin test may be
strongly positive in contrast to severely dissemi-
nated coceidioidomyeosis where the reverse may
be observed (2). Isolated meningitis can also occur
without evident involvement of other systems, as
a result of early "seeding" of the meninges during
the acute pulmonary infection.
Other blood tests which have been found to be
TABLE II
Severity of infection by sex and race
TABLE III
Type of infection by sex and race
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TABLE V
Relationship of complemenl fixation titer to skin
test reactions
SkinTest ,., 9
lststrength 1 1 2 2 2 5 2 2 0
positive
2ndstrength 0 1 2 1 0 0 0 1 2
positive
negative 0 1 1 3 4 2 2 1 2
13 5 6 6 7 4 4 4
clinically useful in prognosis and objective evalu-
ation of progression of the infection include the
leukocyte count, determination of the degree of
eosinophilia, the hematocrit (HOT), and the
erythrocyte sedimentation rate (ESR). Leuko-
cytosis may initially indicate the severity of the
primary infection, but after dissemination it is of
less significance. Eosinophilia may be associated
with erythema nodosum. Very high eosinophilia
may also be seen however, with prolonged pulmo-
nary infiltration and may herald dissemination of
the infection (2).
Progressive infection is frequently associated
with a significant dysproteinemia, manifested by
increased globulins and decreased albumin. Simple
chemical determination of the serum and albumin,
however, have been used empirically by some
clinicians in endemic areas to aid them in evalu-
ating the severity of the disease. The serum al-
bumin and globulin was determined in 25 cases of
disseminated coecidioidomycosis before and after
amphotericin therapy. Prior to treatment the
mean albumin was 3 gm/lOU cc with a range of
2 to 4.5 and the mean globulin was 3.9 gm/lOU cc
with a range of 2.2 to 5.6. After 3 months of therapy
the mean albumin was 4 gm/lOU cc with a range
of 3 to 5 and the mean globulin, 2.8 gm/100 cc
with a range of 2 to 4.6. In a preliminary survey of
the dysproteinemias of a variety of clinically
discrete diagnostic categories it was observed that
patients with coccidioidomycosis had significantly
elevated serum glycoprotein levels (21). The serum
protein profiles (SPP) of the individual patients
showed considerable variation however. A pre-
liminary review of the data indicated an apparent
correlation of the degree of abnormality with the
physician's subjective evaluation of the severity
of the infection. Because of the frequent vagaries
of progressive coccidioidomycosis and the diffi-
culty of objective clinical evaluation of the
severity of infection, the need for additional
laboratory aids in diagnosis, prognosis, and
therapy is apparent.
EXPERIMENTAL
Clinical Material
The patients were selected in sequence from
those admitted to Kern County General Hos-
pital, Bakersfield, California, because of eoeeidi-
oidomycosis. (Table I). Inasmuch as it has pre-
viously been demonstrated that the SPP has
little diagnostic specificity when considered as
isolated data, patients with all forms of infection
were grouped for the purpose of testing eorre-
lations with conventional clinical tests. All
patients were additionally categorized according
to the physician's clinical estimate of the severity
of infection into three groups having relatively
"mild", "moderate", and "severe" disease. In
making this categorization, all available clinical
data, exclusive of laboratory tests, were con-
sidered, such as severity of malaise (toxicity),
clinical evidence of inflammation, fever, and the
apparent response to therapy.
Immunochemical Methods
Serum was stored at .—10 C and remained in
a thawed state for not more than 24 hours prior
to testing. Total serum proteins (TSP) and
glyeoproteins (TSGP) were determined by
methods previously described (22). Serum eleetro-
phoretic patterns were determined with the
Spineo system (23), using the periodic-acid-
Schiff stain and the Model RB Analytrol for
quantitation. C-reactive protein levels were de-
termined by a quantitative gel-diffusion technic
(24).
The absolute protein and glycoprotein content
in each electrophoretie fraction was computed
from the product of the total serum concentration
and the relative percent of total migrating in the
individual electrophoretie fractions.
REsULTS
Relationship of Clinical Tests to Severity of
Infection
The mean hematocrit value, complement fix-
ation titer and erythroeyte sedimentation rate
were all significantly different for the three
categories grouped by clinical estimates of the
severity of infection (Figs. 1, 2 and 3). The
complement fixation titers and erythroeyte sedi-
mentation rates showed a progressive increase
with severity of infection, but with considerable
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overlap of the values from group to group. The
hematoCrit values showed relatively little differ-
ence between the groups with "mild" and
"moderate" infection, but there was almost no
overlap of values of these two groups with the
lower values observed in the group with "severe"
infection. The lower hematocrit values were
usually associated with severe infection.
Relationship of Electrophoretic Frwtions to
,Severity of Infection
Values for the serum protein fractions (concen-
tration in grams of milligrams percent) which
showed significant differences related to a pro-
gressive increase in severity of infection included
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FIG. 3
the total serum glycoprotein, gamma-i protein,
alpha-i glycoprotein, total beta-glycoprotein, and
both albumin protein and glycoprotein (Tables
VI and VII, Fig. 4). However, there were no
significant differences in the electrophoretic pat-
terns of glycoproteins when judged only by their
relative percent distribution, except for a pro-
gressive decrease in the percent migrating in the
albumin fractions (Tables VI and VII, Fig. 5).
The electrophoretic patterns of the proteins,
however, showed significant differences with re-
spect to the percent which migrated as gamma-i
protein and albumin, showing a progressive in-
crease and decrease, respectively, with increasing
severity of infection.
Correlation of Electrophoretic Fractions with
Clinical Tests
Of the protein fractions, both the absolute and
relative concentrations of albumin and gamma-i
protein showed significant correlations with the
complement fixation titer and ESR (Table VIII).
There was less correlation of these fractions with
the hematocrit. Both the absolute and relative
concentration of the alpha-2 fraction showed a
significant positive correlation with the ESR, a
negative correlation with the HOT, and no sig-
nificant correlation with the complement fixation
titer.
The total serum glycoproteins showed a sig-
nificant correlation with the complement fixation
titer and ESR, but none with the HCT. Most of
this increase was due to smaller increases in the
alpha-2 and beta-2 glycoprotein electrophoretic
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TABLE VI
Mean serum protein values for patients grouped according to severity of infection
N TSP Aib. at a 72 72
Absolute Values (Protein)
Mild
Moder-
ate
Severe
14
17
9
M
S.D.
M
S.D.
M
S.D.
7.94
.68
7.56
.74
7.98
.74
4.09
.52
3.49
.62
3.17
.97
.395
.09
.369
.10
.402
.13
.707
.27
.674
.17
.800
.18
.390
.10
.426
.12
.463
.11
.607
.16
.604
.10
.584
.19
.990
.27
1.218
.32
1.581
.59
.770
.18
.802
.26
.996
.42
.994
.22
1.028
.16
1.048
.27
1.759
.41
2.018
.49
2.578
.98
F-Ratio 1.484 4.638* 2.995 3.959 1.119 .696 5.985t 1.82 .183 4.498*
Relative Per Cent Values (Protein)
Mild
Moder-
ate
Severe
14
17
9
M
S.D.
M
S.D.
M
S.D.
51.66
7.8
45.88
7.4
39.74
12.0
4.96
1.1
4.91
1.5
5.06
1.6
8.83
2.9
8.92
2.3
10.20
2.8
4.88
1.2
5.67
1.5
5.84
1.3
7.61
1.8
8.04
1.4
7.33
2.3
12.43
3.2
16.00
3.8
19.44
5.8
9.61
1.8
10.54
3.1
12.34
.44
12.49
2.3
13.70
2.1
13.17
3.1
22.05
4.6
26.55
5.6
31.78
9.8
5.69F-Ratio 4.71* .0027 0.794 1.645 .472 7.44f 1.96 .843
(F-Ratio: P = *0.05, tOol)
TABLE VII
Mean serum glyco protein value for patients grouped according to severity of infection
TGP Aib. at at $1 fit 71 72
Absolute Values (Glycoprotein)
Mild
Moder-
ate
Severe
M
S.D.
M
S.D.
M
S.D.
F-Ratio
120.9
11.8
140.8
24.8
161.5
27.2
8.903f
9.59
5.7
6.48
2.3
5.34
2.3
3.731*
26.55
4.3
34.50
12.7
40.35
11.2
4933*
34.40
10.0
44.41
12.9
55.02
17.0
6.363t
14.05
4.4
16.50
2.8
17.00
2.7
13.83
4.1
16.99
4.1
17.86
4.1
9.36
3.5
9.96
5.2
10.97
2.9
[3.21
3.9
11.99
4.6
15.01
6.6
27.88
7.2
33.49
5.9
34.84
3.9
22.57
5.4
21.94
8.7
25.97
7.9
2.536 3.175 .337 .795 4.4l0 .836
Relative Per Cent Values (Glycoprotein)
Mild
Moder-
ate
Severe
M
S.D.
M
S.D.
M
S.D.
8.05
5.1
4.77
1.9
3.42
1.7
22.05
4.2
24.02
6.1
24.70
4.2
28.33
7.5
31.30
6.5
33.5
5.9
11.55
3.4
11.94
2.2
10.78
2.4
11.35
2.9
12.18
2.6
11.20
2.5
7.67
2.5
7.07
3.1
6.84
1.7
10.95
3.4
8.70
3.4
9.34
4.2
22.90
5.1
24.12
3.9
22.0
3.3
18.60
4.0
15.77
5.7
16.1
4.8
F-Ratio 5.59f .78 1.607 .48 .48 .26 1.425 .692 1.246
(F-Ratio:P = *0.05, fOol)
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* Significant at the 0.05 level.
t Significant at the 0.01 level.
All values include the standard error of n.
TABLE VIII
Glycoprotein
CF ESR HCT
mg% % mg% % mg% %
.427f .600f — .260
—
.301 — 373* .214 — .330 .392* .527f
.188 —.077 .272 .003 —.221 .127
.437t .324 .496t .254 — 443* 479t
.094 —.242 .192 — .205 .060 .249
.427f .164 .524f .219 .071 .228
.267 .068 .254 .006 .163 .269
.089 —
.115 .040 — .186 — .032 .147
.105 —
.052 .238 .006 .081 .307
.207 —.049 .201 — .128 .077 .250
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Correlation coefficients between protein and glycoprotein elect rophoretic fractions, absolute (gm % or my %)
and relative (%), and the complement fixation test (CF), erythrocyte sedimentation
rate (ESR), and hematocrit (HCT)
Fia. 5
Protein
CF
gm% %
Total .160
Alb. — .458f — .534f
a-i .050 .006
a-2 .320 .302
jl-i .221 .174
—
.035 — .090
.544t .552t
.490f .200
jlt .104 .035
.563k .583f
n 40
ESR
gin% %
.189
—
.474t — . 528t
.080 .005
.516t .522f
.413* .389*
.189 .141
.486f ,485t
.273 .264
.337 .303
.442t 444*
35
HCT
gm% %
.050
.367* .344
—
.040 — .075
—
.370*— .376*
—
.322 — .316
.259 .219
—
.303 — .313
—
.105 — .111
—
.030 — .045
—
.419* — .258
33
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Mild 12 2
Moderate 6 11
Severe 2 7
Incidence of C-reactive protein in patients
with coccidioidomycosis categorized according to
clinical severity of infection.
fractions. The hematocrit correlated positively
with the absolute and relative concentration of
glycoprotein in the albumin electrophoretic frac-
tion, and negatively with that in the alpha-2
fraction.
Relationship of C-Reactive Protein to Severity of
Infection
C-reactive protein was also significantly associ-
ated with a progressive increase in severity of
infection (Table IX). Only 2 of 14 patients with
"mild" disease had a positive reaction, whereas
only S of 26 patients with more severe infections
were negative.
Relationship of Serum Protein Profiles to the
Clinical Type of Disease
There was no characteristic serum protein
profile for the various clinical types of disease. For
the four patients with meningitis however, it is
interesting that there was little alteration of the
protein patterns, although significant increases
were noted in the alpha glycoproteins. Two of
these patients however, also had lesions outside
the central nervous system (pulmonary in one,
and osseous and cutaneous in the other). The
four patients with solitary benign lesions showed
relatively normal patterns for proteins and glyco-
proteins with the exception of increases in alpha-i
glycoprotein. Alpha glycoprotein increases have
been observed to be associated with inflammation,
and these increases may signify continued active
inflammation in these patients.
DI5USSION
The value of the present laboratory tests in the
management of patients with coccidioidomycosis
has been demonstrated in many carefully con-
trolled clinical studies. Of these tests, the comple-
ment fixation test is generally considered to
reflect best the severity of the infection. Even
when this test is readily available, however, there
is a need for additional objective and independent
laboratory tests to aid in the management of
coccidioidomycosis. The serum protein profile,
when judiciously interpreted in light of other
clinical and laboratory data, is a valuable ad-
ditional measure of the severity of the infection.
Unlike the complement fixation test, however,
the abnormalities of the serum protein profile
have no diagnostic or etiologic specificity. The
available clinical evidence indicates that the
total serum glycoproteins, particularly those of
the alpha-i and alpha-2 fractions primarily re-
flect inflammation. It is also widely assumed that
the increases in the gamma, and possibly beta-2,
proteins reflect, to some extent, antibody for-
mation. Recent studies have, however, demon-
strated considerable physico-chemical and im-
munologic heterogeneity of these fractions, and
it is likely that in patients with very high values,
only a relatively small portion of this fraction,
when considered gravimetrically, would consist
of specific antibodies to Coccidioides.
Inferences from the data of this study indicate
that variations in the complement fixation titer,
ESR, and HCT possibly reflect different patho-
physiologic phenomena. The complement fixation
titer, which presumably is a direct measurement
of a specific antibody response, shows a significant
correlation with the absolute and relative concen-
trations of gamma globulin, consistent with an
antibody response. It is assumed that the negative
correlation with albumin is due primarily to the
nonspecific decrease in this fraction observed in
most severe infections or inflammatory diseases
associated with indirect nutritional effects on the
serum proteins.
The correlation of the ESR with the alpha-2
protein and glycoprotein fractions is less readily
explained. Increases in the ESR have been
attributed to increased fibrinogen, globulins, and
haptoglobin. Previous studies of the serum pro-
tein profiles of infectious and inflammatory
diseases of diverse etiology have demonstrated a
correlation between the alpha-2 protein and,
particularly, the alpha-2 glycoprotein fraction,
and the degree of inflammation (21). Assuming
this relationship exists in coccidioidomycosis, the
ESR would appear to correlate with the degree of
inflammation as well as the antibody response.
The hematocrit was relatively normal in the
patients with "mild" and "moderately" severe
TABLE IX
Severity of Infection
C-Reactive Proteio
Negative Positive
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infection, showing relatively little depression
until the infection was "severe". There was also
relatively less correlation between the hematocrit
and the protein electrophoretic fraction. The
relative concentrations of the albumin and
alpha-2 glycoprotein fractions, however, showed
a closer correlation.
The physician's clinical estimate of the severity
of the infection showed many significant corre-
lations with objective laboratory determinations.
The value of the hematoerit in estimating se-
verity of infection is limited somewhat by the
lack of a significant decrease until the infection
has become extensive, but the small overlap of
values of patients with "severe" infections with
those having "mild" and "moderate" infection
indicates a relatively high degree of specificity.
The complement fixation titer showed more
variation due to severity of infection than did
the ESR. The increase in these two measurements
was also progressive through all three clinical
categories, indicating their value in detecting
dissemination following the primary infection.
The complement fixation titer appears to be the
more reliable of the two, because of its specificity
and possibly greater sensitivity. Because of its
relative complexity and limited availability, how-
ever, and the simplicity and frequency with
which the ESR can be determined, it is likely
that the latter will be the more useful routine
test for the purpose of clinical management using
the test only at monthly or hi-monthly intervals.
Testing for C-reactive protein, which is never
found in the serum of healthy subjects and is
usually associated with clinically significant in-
flammation, may be of value in the clinical
management of eoeeidioidomyeosis. Most patients
who had extensive pulmonary or extra-pulmonary
disease had C-reactive protein in their serum,
whereas those with mild infections were usually
negative. The principal limitation of this test is
its non-specificity, inasmuch as it may also be
positive due to infammation from causes other
than eoecidioidomyeosis.
The applications of serum protein analysis in
the clinical management of coccidioidomycosis
requires more extensive evaluation, particularly
with respect to longitudinal studies in individual
patients. It compared favorably in this cross-
sectional study with other methods for estimating
the extent of disease. It is more easily standard-
ized than the complement fixation titer test, but
lacks the diagnostic specificity of the latter. It is
probable that its main value will be its use as an
additional, independent, and objective laboratory
test which may be clinically useful in measuring
the response of the host to his disease.
sUMMARy
1. Forty patients with eoeeidioidomyeosis were
studied by conventional clinical methods and
serum protein analysis.
2. With increasing severity of infection, there
was a corresponding decrease in albumin protein,
albumin glyeoprotein, and increase in gamma
protein.
3. Changes in individual protein fractions could
be significantly correlated with conventional
laboratory tests such as the complement fixation
test, erythroeyte sedimentation rate, and hemato-
crit.
4. The changes in the alpha-2 glycoproteins,
erythrocyte sedimentation rate, and hematocrit
appeared to be related to the degree of inflam-
mation; whereas changes in the gamma protein
and beta-2 glycoprotein appeared to be related
to the specific antibody response.
5. Serum protein analysis is a valuable addition
to present methods for evaluation of the indi-
vidual patient with eoeeidioidomycosis.
REFERENCES
1. WILSON, J. W.: Clinical and Immunologic
Aspects of Fungous Diseases. Springfield,
Ill., Charles C Thomas, 1957.
2. Frass, M. J.: Coeeidioidomyeosis. Springfield,
Ill., Charles C Thomas, 1958.
3. BAUM, G. L. AND ScHwARz, J.: Coeeidioidomy-
cosis, a review. Amer. J. Med. Sci., 230:
82—97, 1955.
4. HUNTINGTON, R. W.: Pathologic and clinical
observations on eoeeidioidomyeosis. Wis -
eonsin Med. J., 58: 471—478, 1958.
5. Foaxs, W. D. AND BESTEBREURTJE, A. M.:
Coecidioidomycosis: a study of 95 cases of
the disseminated type with special reference
to the pathogenesis of the disease. Mil.
Surgeon, 99: 653—719, 1946.
6. WILSON, J. W., SMITH, C. E. AND PLUNKETT,
0. A.: Primary cutaneous eoeeidioidomyco-
sis. Criteria for diagnosis. Calif. Med., 79:
233—239, 1953.
7. GIFFORD, M. A., BASS, W. C. AND DoUns,
R. J.: Data on eoeeidioides fungous infec-
tion, Kern County 1900-1936. Kern County
Health Dept. Ann. Rep., pp. 39—54. 1936—
1937.
8. SMALE, L. E. AND BINSNER, J. W.: Maternal
deaths from eoeeidioidomyeosis. J.A.M.A.,
140: 1152—1153, 1949.
9. VAuGHN, J. W. AND RAMIEEZ, H.: Coccidio-
idomyeosis as a complication of pregnancy.
Calif. Med., 74: 121—125, 1951.
10. EINSTEEN, H. B. AND HOLEMAN, C. W.:
158 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
Coccidioidal meningitis—the use of Am-
photericin B in treatment and personal
communication. Calif. Med., 94: 339—342,
1961.
11. Cooxs, J. V.: Immunity tests in coccidioidal
granuloma. Proc. Soc. Exp. Biol. Med.,
12: 35, 1914.
12. DAVIS, D. J.: Coccidioidal granuloma with
certain serological and experimental ob-
servations. Arch. Dermat. & Syph., 9:
577—587, 1924.
13. JAcoBsoN, H. P.: Coccidioidal granuloma:
specific allergic cutaneous reaction; experi-
mental and clinical investigations. Arch.
Dermat. & Syph., 18: 562—567, 1928.
14. HA55ID, W. Z., BAKER, E. E. AND MCCHEADT,R. M.: An immunologically active poly-
saccharide produced by coccidioides immitis.
Pixford and Gilchrist. J. Biol. Chem.,
149: 303—311, 1943.
15. SMITH, C. E., WHITING, E. G., BAKER, E. E.,
RO5ENBERGER, H. G., BEARD, R. R. ANDSAIT0, M. T.: The use of coccidioidin.
Ann. Rev. Tuberc., 57: 330—360, 1948.
16. SMITH, C. E., SAITO, M. T., BEARD, R. R.,
ROSENBEHGEE, H. C. AND WHITING, E. C.
Histoplasmin sensitivity and coccidioidal
infection; occurrence of cross-reactions.
Amer. J. Pub. Health, 39: 722—736, 1949.
17. WILsoN, J. W.: Coceidioidomycosis as a tool
in the study of granulomatous disease.
Calif. Med., 78: 257—262, 1953.
18. SMITH, C. E., SAIT0, M. T., BEARD, H. H.,
KEPP, H. Mc., CLARK, R. W. AND EDDIE,
B. U.: Serological tests in the diagnosis and
prognosis of coecidioidomycosis. Amer. J.
Hyg., 52: 1—21, 1950.
19. SMITH, C. E., SAIT0, M. T. AND SIM0N5, S. A.:
Pattern of 39,500 serologic tests in eoceidio-
idomycosis. J.A.M.A., 160: 546—552, 1956.
20. SMITH, C. E. AND SAlvo, M. T.: Serologic
reactions in eoccidioidomyeosis. J. Chron.
Dis., 5: 571—579, 1957.
21. HHISKHLL, CHARLES L., CARPENTER, CHARLEs
M., WHIHEE, HENRI' E. AND NAKAGAWA,
51101cm.: Serum glyeoproteins in infectious
and inflammatory diseases. Ann. N. Y.
Aead. Sei., 94: 183—209, 1961.
22. WHIMER, H. E. AND MIO5HIN, J. R.: Serum
glycoprotein concentrations in experimental
tuberculosis of guinea pigs. Amer. Rev.
Tuberc., 68: 594—602, 1.952.
23. MODEL, H.: Paper Electrophoresis SystemInstruction Manual. Beckman, Spineo Di-
vision, Stanford Industrial Park, Palo Alto,
Calif.
24. FUKUDA, M., HEISKHLL, C. L. AND CARPENTER,
C. M. :Amethod for quantitative determina-
tion of C-reactive protein using gel-diffusion.
Amer. J. Clin. Path., 32: 507—512, 1959.
DUES
To insure uninterrupted receipt of The Journal of Investigative Derma-
tology it is imperative that 1963 Society for Investigative Dermatology
membership dues, $20.00, be sent AT ONCE to: Dr. Herman Beerman,
Treasurer, 255 South 17th St., Philadelphia 3, Penna.
